Fragment-Based Drug Discovery Market 2021


Roots Analysis

<b>Roots Analysis is pleased to announce the publication of its recent study, titled, “</b>Fragment-based Drug Discovery Market <b>: Library and Service Providers, 2020-2030.”</b>

<b>Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery</b>

<b>The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:</b>

· A detailed review of the overall landscape of fragment-based drug discovery library and service providers.

· Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).

· An analysis of the partnerships that have been established in the recent past.

· A detailed analysis on acquisition targets.

· An insightful competitiveness analysis of fragment-based drug discovery library and service providers.

· An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.

<b>Get Detailed Analysis: </b>

<b>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)</b>

<b>Type of Technique</b>

· X-ray Crystallography

· Nuclear Magnetic Resonance

· Surface Plasmon Resonance

· Other Screening Techniques

<b>Type of Service</b>

· Library Screening

· Fragment Screening

· Fragment Optimization

<b>End User</b>

· Industry Players

· Non-Industry Players

<b>Key Geographical Region </b>

· North America (US and Canada)

· Europe (UK, France, Germany, Spain, Italy, and rest of Europe)

· Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

<b>Key companies covered in the report</b>

· 2bind

· Charles River Laboratories

· ChemAxon

· ComInnex

· Creative Biolabs

· Creative Biostructure


· Domainex

· Evotec

· Red Glead Discovery

· SARomics Biostructures

· Shanghai ChemPartner

· Sygnature Discovery

· Vernalis Research

<b>Request for Customization: </b>


PopularIn orderChat mode

No replies yet

Be the first one to reply to wilsonstella522

Joined discussion